We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current NERV market cap is 17.04M. The company's latest EPS is USD -4.2905 and P/E is -0.57.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -5.21M | -5.07M | -5.35M | -4.52M | -6.08M |
| Net Income | -6.82M | -6.73M | -6.97M | -6.19M | -7.82M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 41.18M | 0 | 0 | 0 |
| Operating Income | -75.87M | 1.85M | -45.37M | -25.23M | -23.12M |
| Net Income | -72.18M | 1.94M | -49.91M | -32.11M | -30.01M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 59.76M | 55.09M | 51.6M | 67.14M | 63.13M |
| Total Liabilities | 74.01M | 75.11M | 78.21M | 79.65M | 83.18M |
| Total Equity | -14.25M | -20.02M | -26.62M | -12.51M | -20.05M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 77.5M | 57.63M | 77.12M | 55.09M | 56.9M |
| Total Liabilities | 49.72M | 4.96M | 69.15M | 75.11M | 85.36M |
| Total Equity | 27.78M | 52.66M | 7.98M | -20.02M | -28.46M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -20.54M | -24.65M | -116k | -3.99M | -8.79M |
| Investing | N/A | -16k | N/A | N/A | N/A |
| Financing | N/A | N/A | N/A | 19.69M | 19.6M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -43.43M | -33.82M | -24.6M | -24.65M | -14.79M |
| Investing | 14.09M | 24.53M | N/A | -16k | N/A |
| Financing | 525k | 13.24M | 60M | N/A | 19.6M |
| Market Cap | 17.04M |
| Price to Earnings Ratio | -0.57 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.42 |
| Price to Book Ratio | -0.6 |
| Dividend Yield | - |
| Shares Outstanding | 6.99M |
| Average Volume (1 week) | 7.14k |
| Average Volume (1 Month) | 17.25k |
| 52 Week Change | 5.48% |
| 52 Week High | 13.49 |
| 52 Week Low | 2.2864 |
| Spread (Intraday) | 0.12 (4.8%) |
| Company Name | Minerva Neurosciences Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.minervaneurosciences.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
